Cargando…

Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2

Pseudoviruses are useful virological tools because of their safety and versatility, especially for emerging and re-emerging viruses. Due to its high pathogenicity and infectivity and the lack of effective vaccines and therapeutics, live SARS-CoV-2 has to be handled under biosafety level 3 conditions...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nie, Jianhui, Li, Qianqian, Wu, Jiajing, Zhao, Chenyan, Hao, Huan, Liu, Huan, Zhang, Li, Nie, Lingling, Qin, Haiyang, Wang, Meng, Lu, Qiong, Li, Xiaoyu, Sun, Qiyu, Liu, Junkai, Fan, Changfa, Huang, Weijin, Xu, Miao, Wang, Youchun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144318/ https://www.ncbi.nlm.nih.gov/pubmed/32207377 http://dx.doi.org/10.1080/22221751.2020.1743767

Ejemplares similares

The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity
por: Li, Qianqian, et al.
Publicado: (2020)

HIV-1 pseudoviruses constructed in China regulatory laboratory
por: Nie, Jianhui, et al.
Publicado: (2019)

Development of in vitro and in vivo rabies virus neutralization assays based on a high-titer pseudovirus system
por: Nie, Jianhui, et al.
Publicado: (2017)

Development of a Bioluminescent Imaging Mouse Model for SARS-CoV-2 Infection Based on a Pseudovirus System
por: Wu, Xi, et al.
Publicado: (2023)

Development of an automated, high-throughput SARS-CoV-2 neutralization assay based on a pseudotyped virus using a vesicular stomatitis virus (VSV) vector
por: Liang, Ziteng, et al.
Publicado: (2023)

Nipah pseudovirus system enables evaluation of vaccines in vitro and in vivo using non-BSL-4 facilities
por: Nie, Jianhui, et al.
Publicado: (2019)

Functional comparison of SARS-CoV-2 with closely related pangolin and bat coronaviruses
por: Nie, Jianhui, et al.
Publicado: (2021)

Development of a Triple-Color Pseudovirion-Based Assay to Detect Neutralizing Antibodies against Human Papillomavirus
por: Nie, Jianhui, et al.
Publicado: (2016)

SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escape
por: Li, Qianqian, et al.
Publicado: (2021)

Screening and identification of HTNV(pv) entry inhibitors with high-throughput pseudovirus-based chemiluminescence
por: Wen, Xiaojing, et al.
Publicado: (2022)

Packaging of Rift Valley fever virus pseudoviruses and establishment of a neutralization assay method
por: Li, Yuetao, et al.
Publicado: (2018)

Reduced sensitivity of the SARS-CoV-2 Lambda variant to monoclonal antibodies and neutralizing antibodies induced by infection and vaccination
por: Wang, Meiyu, et al.
Publicado: (2021)

A Pseudovirus-Based Entry Assay to Evaluate Neutralizing Activity against Respiratory Syncytial Virus
por: Hu, Longbo, et al.
Publicado: (2023)

Comparison of Two High-Throughput Assays for Quantification of Adenovirus Type 5 Neutralizing Antibodies in a Population of Donors in China
por: Liu, Qiang, et al.
Publicado: (2012)

Analysis of SARS-CoV-2 variants B.1.617: host tropism, proteolytic activation, cell–cell fusion, and neutralization sensitivity
por: Zhang, Li, et al.
Publicado: (2022)

Cellular tropism and antigenicity of mink-derived SARS-CoV-2 variants
por: Zhang, Li, et al.
Publicado: (2021)

A Novel High-Throughput Vaccinia Virus Neutralization Assay and Preexisting Immunity in Populations from Different Geographic Regions in China
por: Liu, Qiang, et al.
Publicado: (2012)

A simple and safe antibody neutralization assay based on polio pseudoviruses
por: Jiang, Zheng, et al.
Publicado: (2018)

Establishment of a neutralization assay for Nipah virus using a high-titer pseudovirus system
por: Luo, Xiaoyi, et al.
Publicado: (2023)

Establishment of a pseudovirus neutralization assay based on SARS-CoV-2 S protein incorporated into lentiviral particles
por: Wang, Sheng, et al.
Publicado: (2022)

Ten emerging SARS-CoV-2 spike variants exhibit variable infectivity, animal tropism, and antibody neutralization
por: Zhang, Li, et al.
Publicado: (2021)

Unmethylated CpG motif-containing genomic DNA fragments of bacillus calmette-guerin improves immune response towards a DNA vaccine for COVID-19
por: Zhou, Zehua, et al.
Publicado: (2021)

Cross-reactivity of eight SARS-CoV-2 variants rationally predicts immunogenicity clustering in sarbecoviruses
por: Li, Qianqian, et al.
Publicado: (2022)

A broader neutralizing antibody against all the current VOCs and VOIs targets unique epitope of SARS-CoV-2 RBD
por: Liu, Shuo, et al.
Publicado: (2022)

Sera from breakthrough infections with SARS-CoV-2 BA.5 or BF.7 showed lower neutralization activity against XBB.1.5 and CH.1.1
por: Liu, Shuo, et al.
Publicado: (2023)

Three epitope-distinct human antibodies from RenMab mice neutralize SARS-CoV-2 and cooperatively minimize the escape of mutants
por: Nie, Jianhui, et al.
Publicado: (2021)

Structural characterization of a neutralizing mAb H16.001, a potent candidate for a common potency assay for various HPV16 VLPs
por: Huang, Weijin, et al.
Publicado: (2020)

Development of in vitro and in vivo neutralization assays based on the pseudotyped H7N9 virus
por: Tian, Yabin, et al.
Publicado: (2018)

A practical method for evaluating the in vivo efficacy of EVA-71 vaccine using a hSCARB2 knock-in mouse model
por: Wu, Yong, et al.
Publicado: (2021)

Antigenicity comparison of SARS‐CoV‐2 Omicron sublineages with other variants contained multiple mutations in RBD
por: Li, Qianqian, et al.
Publicado: (2022)

A second functional furin site in the SARS-CoV-2 spike protein
por: Zhang, Yue, et al.
Publicado: (2022)

The significant immune escape of pseudotyped SARS-CoV-2 variant Omicron
por: Zhang, Li, et al.
Publicado: (2021)

The Antigenicity of Epidemic SARS-CoV-2 Variants in the United Kingdom
por: Wu, Jiajing, et al.
Publicado: (2021)

Comparison of the genotypic and phenotypic properties of HIV-1 standard subtype B and subtype B/B′ env molecular clones derived from infections in China
por: Xie, Hui, et al.
Publicado: (2018)

Characterization of Chronic Hepatitis E Virus Infection in Immunocompetent Rabbits
por: Liang, Chunnan, et al.
Publicado: (2022)

A Simplified SARS-CoV-2 Pseudovirus Neutralization Assay
por: Donofrio, Gaetano, et al.
Publicado: (2021)

体积排阻色谱法定量检测9种型别人乳头瘤病毒原液中病毒样颗粒
por: LONG, Zhen, et al.
Publicado: (2021)

Biodistribution and residence time of adenovector serotype 5 in normal and immunodeficient mice and rats detected with bioluminescent imaging
por: Liu, Qiang, et al.
Publicado: (2017)

Application of pseudovirus system in the development of vaccine, antiviral-drugs, and neutralizing antibodies
por: Xiang, Qi, et al.
Publicado: (2022)

Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody
por: Lv, Zhe, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3a2aps8ifjnh4ec4k7h999aq6e